tesamorelin if visceral fat is the primary target Starting dose 50% of standard adult dose, titrated up over 46 weeks based on IGF-1 response and side effect tolerance Administration subcutaneous injection, typically at bedtime to align with natural GH pulsatility 8-week reassessment IGF-1, fasting glucose, HbA1c, symptom review, body composition measurement Ongoing monitoring every 812 weeks
7 assorted flavor pouches per box (2 Vanilla, 2 Chocolate, 2 Chocolate Salted Caramel, 1 Strawberries and Cream)
There is no known harmful interaction between NAD+ therapy and GLP-1 medicines such as Mounjaro
10.1016/j.cellsig.2022.110508 116 ZengJ.WuL.XieH.LiuW.ShenN.LuoH
Hims & Hers' stock surged more than 30% on Monday in response to the news
In Your Brain GLP-1 boosts dopamine, helping with weight management and possibly treating certain addictive behaviors